(Q52475609)

2 May 2018

title

Maintenance therapy with a new retard tablet preparation of procainamide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

author name string

V. Hansteen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

K. H. Landmark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

D. Fremstad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

S. G. Dahl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

S. Jacobsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

A. A. Marthinsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

T. Waaler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

K. Frislid

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

P. K. Lunde

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A785987

28 July 2022

language of work or name

English

0 references

publication date

1 July 1976

1 reference

2 May 2018

published in

American Heart Journal

1 reference

2 May 2018

volume

92

1 reference

2 May 2018

issue

1

1 reference

2 May 2018

page(s)

47-56

1 reference

2 May 2018

Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Antinuclear antibody induced by procainamide. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

A new sustained-release tablet formulation of procainamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Plasma levels of procaine amide after administration of conventional and sustained-release tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Acetylation of procaine amide in man studied with a new gas chromatographic method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Procainamide Dosage Schedules, Plasma Concentrations, and Clinical Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Long-term use of procaine amide following acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

A coronary-care unit in the routine management of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Effects of N-acetylprocainamide as compared with procainamide in isolated rat atria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

Use of plasma levels in evaluation of procainamide dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

N-acetylprocainamide: an active metabolite of procainamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

inferred from DOI database lookup

7 January 2021

based on heuristic

One year's experience of medical intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2876%2980402-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(76)80402-4

1 reference

2 May 2018

release_us2svqt5bbexxffeapfvzoaok4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/us2svqt5bbexxffeapfvzoaok4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

2 May 2018